In 2016 Janikova et al immunohistochemically evaluated expression of P-gp, MRP and LRP/MVP and quantified the relative levels of miR-23b in 62 NSCLC patients' samples. The gene discussed is PGP; the disease is non-small cell lung carcinoma.